139 related articles for article (PubMed ID: 35864067)
21. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis.
McCarty TR; Paleti S; Rustagi T
Gastrointest Endosc; 2021 May; 93(5):1019-1033.e5. PubMed ID: 33359054
[TBL] [Abstract][Full Text] [Related]
22. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.
Takano S; Fukasawa M; Maekawa S; Kadokura M; Miura M; Shindo H; Takahashi E; Sato T; Enomoto N
PLoS One; 2014; 9(6):e98718. PubMed ID: 24897499
[TBL] [Abstract][Full Text] [Related]
23. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
Shirai Y; Sogawa K; Yamaguchi T; Sudo K; Nakagawa A; Sakai Y; Ishihara T; Sunaga M; Nezu M; Tomonaga T; Miyazaki M; Saisho H; Nomura F
Hepatogastroenterology; 2008; 55(86-87):1824-9. PubMed ID: 19102401
[TBL] [Abstract][Full Text] [Related]
24. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
Nishizawa N; Harada H; Kumamoto Y; Kaizu T; Katoh H; Tajima H; Ushiku H; Yokoi K; Igarashi K; Fujiyama Y; Okuwaki K; Iwai T; Watanabe M; Yamashita K
Cancer Sci; 2019 Sep; 110(9):2846-2855. PubMed ID: 31325200
[TBL] [Abstract][Full Text] [Related]
26. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia.
Kanda M; Sadakari Y; Borges M; Topazian M; Farrell J; Syngal S; Lee J; Kamel I; Lennon AM; Knight S; Fujiwara S; Hruban RH; Canto MI; Goggins M
Clin Gastroenterol Hepatol; 2013 Jun; 11(6):719-30.e5. PubMed ID: 23200980
[TBL] [Abstract][Full Text] [Related]
27. Cytologic Analysis of Pancreatic Juice Increases Specificity of Detection of Malignant IPMN-A Systematic Review.
Tanaka M; Heckler M; Liu B; Heger U; Hackert T; Michalski CW
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2199-2211.e21. PubMed ID: 30630102
[TBL] [Abstract][Full Text] [Related]
28. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
[TBL] [Abstract][Full Text] [Related]
29. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ
J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541
[TBL] [Abstract][Full Text] [Related]
30. Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Singhi AD; George B; Greenbowe JR; Chung J; Suh J; Maitra A; Klempner SJ; Hendifar A; Milind JM; Golan T; Brand RE; Zureikat AH; Roy S; Schrock AB; Miller VA; Ross JS; Ali SM; Bahary N
Gastroenterology; 2019 Jun; 156(8):2242-2253.e4. PubMed ID: 30836094
[TBL] [Abstract][Full Text] [Related]
31. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.
Eshleman JR; Norris AL; Sadakari Y; Debeljak M; Borges M; Harrington C; Lin E; Brant A; Barkley T; Almario JA; Topazian M; Farrell J; Syngal S; Lee JH; Yu J; Hruban RH; Kanda M; Canto MI; Goggins M
Clin Gastroenterol Hepatol; 2015 May; 13(5):963-9.e4. PubMed ID: 25481712
[TBL] [Abstract][Full Text] [Related]
32. Surgical indication for intraductal papillary mucinous neoplasm without mural nodule ≥5 mm.
Tsumura A; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yanagisawa A; Yamaue H
Surgery; 2021 Feb; 169(2):388-395. PubMed ID: 32859391
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma.
Ideno N; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Aso T; Aishima S; Miyasaka Y; Ohuchida K; Ueda J; Takahata S; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2015 Mar; 44(2):311-20. PubMed ID: 25479586
[TBL] [Abstract][Full Text] [Related]
34. Measurement of indicator genes using global complementary DNA (cDNA) amplification, by polyadenylic acid reverse transcriptase polymerase chain reaction (poly A RT-PCR): A feasibility study using paired samples from tissue and ductal juice in patients undergoing pancreatoduodenectomy.
Sanyal S; Siriwardena AK; Byers R
Pancreatology; 2018 Jun; 18(4):458-462. PubMed ID: 29574096
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance.
Suenaga M; Yu J; Shindo K; Tamura K; Almario JA; Zaykoski C; Witmer PD; Fesharakizadeh S; Borges M; Lennon AM; Shin EJ; Canto MI; Goggins M
Clin Cancer Res; 2018 Jun; 24(12):2963-2974. PubMed ID: 29301828
[No Abstract] [Full Text] [Related]
36. Clinical Effect of Driver Mutations of
Gu Y; Ji Y; Jiang H; Qiu G
Genet Test Mol Biomarkers; 2020 Dec; 24(12):777-788. PubMed ID: 33347393
[No Abstract] [Full Text] [Related]
37. High-grade PanIN presenting with localised stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer.
Yokode M; Akita M; Fujikura K; Kim MJ; Morinaga Y; Yoshikawa S; Terada T; Matsukiyo H; Tajiri T; Abe-Suzuki S; Itoh T; Hong SM; Zen Y
Histopathology; 2018 Aug; 73(2):247-258. PubMed ID: 29660164
[TBL] [Abstract][Full Text] [Related]
38. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.
Fukushima N; Walter KM; Uek T; Sato N; Matsubayashi H; Cameron JL; Hruban RH; Canto M; Yeo CJ; Goggins M
Cancer Biol Ther; 2003; 2(1):78-83. PubMed ID: 12673124
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic juice cytology in IPMN of the pancreas.
Yamaguchi K; Nakamura M; Shirahane K; Kawamoto M; Konomi H; Ohta M; Tanaka M
Pancreatology; 2005; 5(4-5):416-21; discussion 421. PubMed ID: 15985766
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of neuronal pentraxin II methylation in patients with pancreatic cancer: Meta-analysis.
Huang W; Xue L; Xu H; Kong Z; Xu J; Zhao H; Nie Y
Int J Clin Pract; 2021 Sep; 75(9):e14443. PubMed ID: 34105851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
